Metformin Atid

Metformin Hydrochloride, the active ingredient in Metformin Atid, is a biguanide presented as an oral tablet for oral use. It is employed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus, improving glycemic control as part of a comprehensive treatment plan.

GNH USA supplies Metformin Atid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable distribution across multiple markets.

Metformin Atid is used in the management of disorders related to impaired glucose regulation, primarily type 2 diabetes mellitus, and may be incorporated into treatment regimens that include diet, exercise, and other antidiabetic agents.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin Atid may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: usually when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, pruritus, or angioedema. - Skin discoloration: rare hyperpigmentation. - Acute pancreatitis: very uncommon inflammatory condition.

When prescribing Metformin Atid, clinicians should consider several safety aspects. - Renal function: assess creatinine clearance before initiating therapy. - Hepatic impairment: use with caution in patients with liver disease. - Lactic acidosis risk: avoid in conditions predisposing to hypoxia (e.g., heart failure, severe infection). - Vitamin B12 monitoring: periodic assessment recommended for long‑term users. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Atid can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol abuse: heightens the likelihood of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics (especially thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes during combined therapy.